Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05249959
Title Consolidation With Loncastuximab Tesirine After a Short Course of Immunochemotherapy in BTKi-treated (or Intolerant) Relapsed/Refractory Mantle Cell Lymphoma Patients. (FIL_COLUMN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Italiana Linfomi ONLUS
Indications

mantle cell lymphoma

Therapies

Bendamustine + Cytarabine + Rituximab

Loncastuximab tesirine-lpyl

Age Groups: senior | adult
Covered Countries ITA


No variant requirements are available.